Skip to main content

Table 3 Relation between Montreal Cognitive Assessment scale and duration of treatment in diabetic subjects

From: Association between microstructural white matter abnormalities and cognitive functioning in patients with type 2 diabetes mellitus: a diffusion tensor imaging study

 

MOCA

Test of sig.

p

Diabetics without MCI (n = 13)

Diabetics with MCI (n = 17)

Duration of treatment(year)

    

 ≤ 2 years

5 (38.5%)

5 (29.4%)

χ2 = 0.271

FEp = 0.705

 > 2 years

8 (61.5%)

12 (70.6%)

Min.–Max.

1.5–6

1–5

U = 74.0

0.133

Mean ± SD

2.8 ± 1.1

3.5 ± 1.3

HbA1c

    

 Good control

0 (0%)

8 (61.5%)

χ2 = 16.467*

MCp = < 0.001*

 Moderate control

4 (30.8%)

7 (41.2%)

 Poor control

1 (7.7%)

10 (58.8%)

  1. χ2 chi-square test, MC Monte Carlo, FE Fisher’s exact, U Mann-Whitney test, p p value for comparing between the studied groups
  2. *Statistically significant at p ≤ 0.05
  3. MoCA Montreal Cognitive Assessment scale, MCI mild cognitive impairment, HbA1c glycosylated hemoglobin.